Hims & Hers Health Inc. (HIMS)
28.20
0.97 (3.56%)
At close: Apr 14, 2025, 3:59 PM
28.16
-0.14%
After-hours: Apr 14, 2025, 07:59 PM EDT
3.56% (1D)
| Bid | 28.16 |
| Market Cap | 6.03B |
| Revenue (ttm) | 1.48B |
| Net Income (ttm) | 126.04M |
| EPS (ttm) | 0.53 |
| PE Ratio (ttm) | 53.21 |
| Forward PE | 32.18 |
| Analyst | Hold |
| Ask | 28.16 |
| Volume | 13,003,153 |
| Avg. Volume (20D) | 25,352,115.3 |
| Open | 28.72 |
| Previous Close | 27.23 |
| Day's Range | 27.20 - 29.00 |
| 52-Week Range | 11.20 - 72.98 |
| Beta | 1.66 |
About HIMS
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmeti...
Industry Household & Personal Products
Sector Consumer Defensive
IPO Date Sep 13, 2019
Employees 1,637
Stock Exchange NYSE
Ticker Symbol HIMS
Website https://www.forhims.com
Analyst Forecast
According to 12 analyst ratings, the average rating for HIMS stock is "Hold." The 12-month stock price forecast is $34, which is an increase of 20.57% from the latest price.
Stock ForecastsNext Earnings Release
Hims & Hers Health Inc. is scheduled to release its earnings on May 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+5.08%
Hims & Hers Health shares are trading higher after...
Unlock content with
Pro Subscription
1 month ago
-15.9%
Hims & Hers Health shares are trading lower following reports suggesting a federal judge ruled in favor of the FDA in the tirzepatide compounding case.
